Radiation Oncology Market Outlook 2023-29

1. Radiation Oncology Market (2023-29) 1

2. Market Overview: The global radiation oncology market size was valued at USD 6,912.3 million in 2022 and is poised to grow at a significant CAGR of 5.6% during the forecast period 2023-29. The radiation oncology market research report also provides opportunities for business owners to exploit through the use of relevant approaches. The study’s prospects assist stakeholders and report purchasers in properly planning their investments and augmenting their profits. The report provides a quantitative analysis of the market segments, trends, estimations, and dynamics of the radiation oncology market analysis from 2023 to 2029 to identify the prevailing market opportunities. In addition, the report discusses the implications of COVID-19, including the industry's initial response and strategies for ensuring business continuity in the coming years. View Detailed Report Description 2

3. Market Segments: The radiation oncology market has been fragmented based on: 1. By Type: External Beam Radiation Therapy, Internal Beam Radiation Therapy 2. By Application: Prostate Cancer, Breast Cancer, Lung Cancer, Head, and Neck Cancer, Colorectal Cancer, Cervical Cancer, Gynecological Cancer, Others 3. By Geography: North America, Asia Pacific, Europe, Middle East, and Africa, Latin America Request Sample Report 3

4. Key Players: Some of the major key players in the radiation oncology market are: Accuray Incorporated IBA Radiopharma Solutions BD (Becton, Dickinson and Company) Isoray Inc. Mevion Medical Systems Nordion, Inc. NTP Radioisotopes SOC Ltd. Request Sample Report 4

5. Europe Office: Precision Business Insights, Kemp House, 152 – 160 City Road, London EC1V 2NX Asia-Pacific Office: Precision Business Insights, MIG 366, SAI PLAZA, 1st Floor, KPHB Colony, Hyderabad – 500072 Email: sales@precisionbusinessinsights.com Toll-Free: +1-866-598-1553 5